Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 20/20 | 0.69 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.55 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.55 |
| ▸ | DGAT2 | Q96PD7 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2452537 | 0.94 | DGAT1 (0.71) | DGAT1SOAT1SOAT2DGAT2CYP3A4 | |
| SCHEMBL2393349 | 0.92 | DGAT1 (0.78) | DGAT1SOAT1SOAT2DGAT2CYP3A4 | |
| SCHEMBL2145914 | 0.88 | DGAT1 (0.66) | DGAT1CYP3A4 | |
| SCHEMBL2395187 | 0.85 | DGAT1 (0.68) | DGAT1 | |
| SCHEMBL2454779 | 0.84 | DGAT1 (0.73) | DGAT1 | |
| SCHEMBL2392842 | 0.84 | DGAT1 (0.76) | DGAT1 | |
| SCHEMBL2393129 | 0.83 | DGAT1 (0.93) | DGAT1CYP3A4 | |
| SCHEMBL2397829 | 0.83 | DGAT1 (0.70) | DGAT1 | |
| SCHEMBL12265245 | 0.83 | DGAT1 (0.84) | DGAT1CYP3A4 | |
| SCHEMBL2392934 | 0.82 | DGAT1 (0.89) | DGAT1SOAT1SOAT2DGAT2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110224137-A1 | INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE | MERCK SHARP & DOHME CORP. | 2011-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224137-A1 | INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE | DGAT2, DGAT1, LCAT | DGAT1 2/4885SOAT1 10/4885SOAT2 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.